SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-16-765100
Filing Date
2016-11-10
Accepted
2016-11-10 07:01:33
Documents
4
Period of Report
2016-12-15
Effectiveness Date
2016-11-10

Document Format Files

Seq Description Document Type Size
1 DEF 14A d71848ddef14a.htm DEF 14A 393808
2 GRAPHIC g71848g58n43.jpg GRAPHIC 8319
3 GRAPHIC g71848g64d68.jpg GRAPHIC 12703
4 GRAPHIC g71848g71i24.jpg GRAPHIC 8930
  Complete submission text file 0001193125-16-765100.txt   436597
Mailing Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071
Business Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071 678-620-3186
GALECTIN THERAPEUTICS INC (Filer) CIK: 0001133416 (see all company filings)

IRS No.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-31791 | Film No.: 161985945
SIC: 2834 Pharmaceutical Preparations